Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-05-19
2000-02-08
Allen, Marianne P.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530350, A61K 3817, C07K 14705
Patent
active
060228563
ABSTRACT:
This invention relates to a purified polypeptide which constitutes the type-2 neurotensin receptor (NT-R2), as well as the nucleotide sequence encoding this polypeptide.
REFERENCES:
Chalon, et al.; "Molecular Cloning Of A Levocabastine-Sensitive Neurotensin Binding Site"; FEBS Letters, vol. 386 May 20, 1996; pp. 91-94.
Mazella, et al.; "Structure, Functional Expression, And Cerebral Localization Of The Levocabastine-Sensitive Neurotensin/Neuromedin N Receptor From Mouse Brain"; The Journal of Neuroscience, 16(18) Sep. 15, 1996; pp. 5613-5619.
Vita, et al.; "Cloning And Expression Of A Complementary DNA Encoding A High Affinity Human Neurotensin Receptor"; FEBS Letters, 317 (1,2), Feb. 8, 1993; pp. 139-142.
Caput Daniel
Chalon Pascale
Ferrara Pascual
Vita Natalio
Allen Marianne P.
Sanofi
LandOfFree
Type-2 neurotensin receptor (NT-R2) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Type-2 neurotensin receptor (NT-R2), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Type-2 neurotensin receptor (NT-R2) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1681566